KIMBERLY CLARK CORP (KMB)
Sector: Consumer Staples
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Consumer Staples
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for KMB
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| KMB | President, Human Health International; Member | 52 | ["Significant experience with accounting matters", "Former Vice President, Investor Relations, Merck & Co., Inc.", "international leadership experience", "deep familiarity with the healthcare space", "understanding of the investor perspective", "strong marketing and innovation experience", "Consumer products", "digital", "M&A", "strategy and transformation", "human capital experience", "audit committee financial expert"] | ["Audit Committee"] | 2026 |
Biography sourced from the proxy statement filing.
President, Human Health International of Merck & Co., Inc., a biopharmaceutical company, since 2022. Chief Executive Officer of JiXing Pharmaceuticals, a China-based biopharmaceutical company, from 2021 to 2022. Served in a number of leadership roles at Merck and Schering-Plough (which merged with Merck in 2009) from 1996 to 2021, including President MSD China from 2016 to 2021. Served approximately seven years in the Investor Relations area and led Merck s Investor Relations team as Vice President, Investor Relations from 2013 to 2015. Other public company boards served on since 2020: None. Experience highlights: Mr. Romanelli has been determined by our Board to qualify as an audit committee financial expert under the SEC s rules and regulations, has leadership experience as a senior executive, provides diversity of background and viewpoint, and has international, innovation and marketing experience.